| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 75 | US FAERS | |
| 2 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 62 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 10 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Hydroxyurea | FAERS: 9 | US FAERS | |
| 5 | Lenalidomide | FAERS: 3 | US FAERS | |
| 6 | bosutinib | FAERS: 3 | US FAERS | |
| 7 | Azathioprine | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Capecitabine | FAERS: 1 | US FAERS | |
| 9 | pazopanib | FAERS: 1 | US FAERS | |
| 10 | venetoclax | FAERS: 1 | US FAERS | |
| 11 | Cytarabine | OFFSIDES | ||
| 12 | Dasatinib | OFFSIDES | ||
| 13 | Etoposide | OFFSIDES | ||
| 14 | Mitoxantrone | OFFSIDES | ||
| 15 | Tenofovir | OFFSIDES | ||
| 16 | Tretinoin | OFFSIDES | ||
| 17 | fludarabine phosphate | OFFSIDES | ||
| 18 | fludarabine | OFFSIDES | ||
| 19 | moexipril | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.